Study of Everolimus (RAD001) in Patients With Recurrent Glioblastoma Multiforme (GBM)

NCT00515086 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
41
Enrollment
INDUSTRY
Sponsor class

Stopped Early termination due to slow enrollment and protocol-defined stopping rule.

Conditions

Interventions

Sponsor

Novartis Pharmaceuticals